{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:04:19Z","timestamp":1792195459685,"version":"4.4.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI109711"],"award-info":[{"award-number":["U19 AI109711"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,22]]},"DOI":"10.1093\/infdis\/jiy293","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T15:09:20Z","timestamp":1528384160000},"page":"S582-S587","source":"Crossref","is-referenced-by-count":33,"title":["Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates"],"prefix":"10.1093","volume":"218","author":[{"given":"Courtney","family":"Woolsey","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrius","family":"Matassov","sequence":"additional","affiliation":[{"name":"Department of Virology and Vaccine Vectors, Profectus BioSciences, Pearl River, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N","family":"Agans","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Cross","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Deer","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla A","family":"Fenton","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Eldridge","sequence":"additional","affiliation":[{"name":"Department of Virology and Vaccine Vectors, Profectus BioSciences, Pearl River, New York"},{"name":"Department of Immunology, Profectus BioSciences, Pearl River, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E","family":"Mire","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"},{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"key\n\t\t\t\t2018112203565794300_CIT0001","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","author":"Cross","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0002","first-page":"1438","article-title":"Phase 2 Placebo-controlled trial of two vaccines to prevent Ebola in Liberia","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0003","first-page":"505","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0004","first-page":"S91","article-title":"Considerations in the use of nonhuman primate models of Ebola virus and Marburg virus infection","volume":"212","author":"Geisbert","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0005","first-page":"9659","article-title":"Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine","volume":"80","author":"Daddario-DiCaprio","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0006","first-page":"1399","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0007","first-page":"1119","article-title":"Postexposure treatment of Marburg virus infection","volume":"16","author":"Geisbert","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0008","first-page":"6497","article-title":"Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola","volume":"80","author":"Towner","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0009","first-page":"S258","article-title":"Comparison of the pathogenesis of the Angola and Ravn strains of Marburg virus in the outbred guinea pig model","volume":"212","author":"Cross","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0010","first-page":"S372","article-title":"Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2","volume":"196","author":"Geisbert","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0011","first-page":"JVI.01190-17","article-title":"Single dose trivalent vesiculovax vaccine protects macaques from lethal Ebolavirus and Marburgvirus challenge","author":"Matassov","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0012","article-title":"Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody","volume":"9","author":"Mire","year":"2017","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0013","first-page":"e0138843","article-title":"Dose response of MARV\/Angola infection in cynomolgus macaques following IM or aerosol exposure","volume":"10","author":"Johnston","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0014","first-page":"360","article-title":"Efficacy of vesicular Stomatitis virus-Ebola virus postexposure treatment in rhesus macaques infected with Ebola virus makona","volume":"214","author":"Marzi","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203565794300_CIT0015","first-page":"281","article-title":"Pathogenicity comparison between the Kikwit and Makona Ebola virus variants in rhesus macaques","volume":"214","author":"Wong","year":"2016","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/suppl_5\/S582\/26689532\/jiy293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T04:00:47Z","timestamp":1542859247000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/suppl_5\/S582\/5043484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":15,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2018,6,25]]},"published-print":{"date-parts":[[2018,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy293","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,6,25]]}}}